Hear it First from our team of Data Science Experts
Here at d-wise we're preparing for our upcoming webinar "Discover a better & faster validated analytical platform" on May 15th. If you're on the fence & trying to decide if this webinar will be for..
Validation software has traditionally always been a source of great frustration for CROs and small/medium Pharma companies. Investing in and maintaining a validated statistical computing..
Validation. A crucial element of the pharmaceutical industry that ensures compliance, protects consumers and ultimately, saves lives. But while it’s undoubtedly a positive part of the process,..
"The purpose of this guidance is to clarify circumstances under which the FDA’s Center for Drug Evaluation and Research (CDER) may refuse to file a new drug application (NDA) or supplemental NDA..
“The EMA’s decision to release clinical trial documents requested in accordance with its Transparency Regulation has been upheld in court after companies filed to suspend the release in 2016.
INNOVATION 100 GREATER MANCHESTER
"BQ and the Business Growth Hub are delighted to launch Innovation 100 Greater Manchester, a new initiative to recognise and support some of Greater Manchester’s..
Why should you attend?
CBI’s 5th Annual Clinical Data Disclosure and Transparency conference will help to navigate regulatory changes at both the U.S. and international level. Develop strategies..
d-Wise appoints VP of d-Wise Europe and establishes German office in response to rapid international growth
- Demand for d-Wise’s clinical trials de-identification solutions soars following new regulatory demands in Europe
- The strategic choice of Frankfurt puts d-Wise in the centre of a major pharmaceutical..
"Companies that handle data are currently faced with constraints placed on them by data protection laws. The EU General Data Protection Regulation (GDPR) will come into effect on May of 2018 and..